Effect of pregabalin augmentation in treatment of patients with combat-related chronic posttraumatic stress disorder: A randomized controlled trial

Journal of Psychiatric Practice

Volumn 20, Issue 6, 2014, Pages 419-427

  Baniasadi, Mehdi ^a   Hosseini, Golkoo ^a   Bordbar, Mohammad Reza Fayyazi ^a   Ardani, Amir Rezaei ^a   Toroghi, Hesam Mostafavi ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chronic posttraumatic stress disorder; Combat stress disorders; Pregabalin; Randomized controlled trial

Indexed keywords

CITALOPRAM; PLACEBO; PREGABALIN; SERTRALINE; VALPROIC ACID; 4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT;

ADULT; ANXIETY; ARTICLE; CHECKLIST; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DSM-IV-TR; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; IRAN; MALE; OUTCOME ASSESSMENT; POSTTRAUMATIC STRESS DISORDER; POSTTRAUMATIC STRESS DISORDER CHECK LIST MILITARY VERSION; PSYCHIATRIC DIAGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SPITZER QUALITY OF LIFE INDEX; ANALOGS AND DERIVATIVES; COMBAT DISORDERS; DRUG POTENTIATION; MIDDLE AGED; PATHOPHYSIOLOGY; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANXIETY; COMBAT DISORDERS; DEPRESSION; DOUBLE-BLIND METHOD; DRUG SYNERGISM; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME; VALPROIC ACID;

EID: 84915754739     PISSN: 15274160     EISSN: 15381145     Source Type: Journal    
DOI: 10.1097/01.pra.0000456590.12998.41     Document Type: Article

References (51)

1. Hendin H, Haas AP. Suicide and guilt as manifestations of PTSD in Vietnam combat veterans. Am J Psychiatry 1991;148:586-91.
2. Magruder KM, Frueh BC, Knapp RG, et al. PTSD symptoms, demographic characteristics, and functional status among veterans treated in VA primary care clinics. J Trauma Stress 2004;17:293-301.
3. Mazza JJ, Reynolds WM. Exposure to violence in young inner-city adolescents: Relationships with suicidal ideation, depression, and PTSD symptomatology. J Abnorm Child Psychol 1999;27:203-13.
4. Galea S, Tracy M, Norris F, et al. Financial and social circumstances and the incidence and course of PTSD in Mississippi during the first two years after Hurricane Katrina. J Trauma Stress 2008;21:357-68.
5. Labinsky E, Blair W, Yehuda R. Longitudinal assessment of dissociation in Holocaust survivors with and without PTSD and nonexposed aged Jewish adults. Ann N Y Acad Sci 2006;1071:459-62.
6. Simons JS, Gaher RM, Jacobs GA, et al. Associations between alcohol use and PTSD symptoms among American Red Cross disaster relief workers responding to the 9/11/2001 attacks. Am J Drug Alcohol Abuse 2005;31: 285-304.
7. Hamner MB. Psychotic features and combat-associated PTSD. Depress Anxiety 1997;5:34-8.
8. Cavaljuga S, Licanin I, Mulabegovic N, et al. Therapeutic effects of two antidepressant agents in the treatment of posttraumatic stress disorder (PTSD). Bosn J Basic Med Sci 2003;3:12-6.
9. Brandes D, Ben-Schachar G, Gilboa A, et al. PTSD symptoms and cognitive performance in recent trauma survivors. Psychiatry Res 2002;110:231-8.
10. Moradi AR, Doost HT, Taghavi MR, et al. Everyday memory deficits in children and adolescents with PTSD: Performance on the Rivermead Behavioural Memory Test. J Child Psychol Psychiatry 1999;40:357-61.
11. Constans JI, Lenhoff K, McCarthy M. Depression subtyping in PTSD patients. Ann Clin Psychiatry 1997;9:235-40.
12. Parslow RA, Jorm AF, Christensen H. Associations of pretrauma attributes and trauma exposure with screening positive for PTSD: Analysis of a community-based study of 2,085 young adults. Psychol Med 2006;36:387-95.
13. Breslau N, Davis GC, Peterson EL, et al. Psychiatric sequelae of posttraumatic stress disorder in women. Arch Gen Psychiatry 1997;54:81-7.
14. Breslau N, Davis GC, Andreski P. Risk factors for PTSDrelated traumatic events: A prospective analysis. Am J Psychiatry 1995;152:529-35.
15. Javidi H, Yadollahie M. Post-traumatic stress disorder. Int J Occup Environ Med 2012;3:2-9.
16. Bokszczanin A. PTSD symptoms in children and adolescents 28 months after a flood: Age and gender differences. J Trauma Stress 2007;20:347-51.
17. Khodaii Ardekani M, Faraji S, Mirabzadeh A, et al. Prazosin effects on clinical symptoms in combat related post traumatic stress disorder. Iranian Journal of War and Public Health 2011;3:54-62.
18. Naifeh JA, North TC, Davis JL, et al. Clinical profile differences between PTSD-diagnosed military veterans and crime victims. J Trauma Dissociation 2008;9:321-34.
19. Pervanidou P, Kolaitis G, Charitaki S, et al. The natural history of neuroendocrine changes in pediatric posttraumatic stress disorder (PTSD) after motor vehicle accidents: Progressive divergence of noradrenaline and cortisol concentrations over time. Biol Psychiatry 2007;62: 1095-102.
20. Glover DA, Poland RE. Urinary cortisol and catecholamines in mothers of child cancer survivors with and without PTSD. Psychoneuroendocrinology 2002;27: 805-19.
21. Goenjian AK, Pynoos RS, Steinberg AM, et al. Hypothalamic-pituitary-adrenal activity among Armenian adolescents with PTSD symptoms. J Trauma Stress 2003; 16:319-23.
22. Southwick SM, Paige S, Morgan CA, 3rd, et al. Neuro-transmitter alterations in PTSD: Catecholamines and serotonin. Semin Clin Neuropsychiatry 1999;4:242-8.
23. Adamec R, Holmes A, Blundell J. Vulnerability to lasting anxiogenic effects of brief exposure to predator stimuli: Sex, serotonin and other factors-Relevance to PTSD. Neurosci Biobehav Rev 2008;32:1287-92.
24. Van Der Kolk BA. The psychobiology and psychopharmacology of PTSD. Hum Psychopharmacol 2001;16(S1): S49-S64.
25. Bandelow B, Zohar J, Hollander E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessivecompulsive and post-traumatic stress disorders-First revision. World J Biol Psychiatry 2008;9:248-312.
26. Hamner MB, Faldowski RA, Robert S, et al. A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry 2009;21:89-94.
27. Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: A randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol 2008;28:84-8.
28. Adamou M, Puchalska S, Plummer W, et al. Valproate in the treatment of PTSD: Systematic review and meta analysis. Curr Med Res Opin 2007;23:1285-91.
29. Van Ameringen M, Mancini C, Pipe B, et al. Antiepileptic drugs in the treatment of anxiety disorders: Role in therapy. Drugs 2004;64:2199-220.
30. Steiner H, Saxena KS, Carrion V, et al. Divalproex sodium for the treatment of PTSD and conduct disordered youth: A pilot randomized controlled clinical trial. Child Psychiatry Hum Dev 2007;38:183-93.
31. Dooley DJ, Mieske CA, Borosky SA. Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neurosci Lett 2000;280: 107-10.
32. Field MJ, Oles RJ, Singh L. Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity. Br J Pharmacol. 2001;132:1-4.
33. Lauer D, Holzel L, Hornyak M. [Generalized anxiety disorder with comorbidity. Treatment with pregabalin] (Article in German). Nervenarzt 2006;77:1363,1365-7.
34. Stein DJ, Baldwin DS, Baldinetti F, et al. Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: A pooled analysis of 6 studies. Eur Neuropsychopharmacol 2008;18:422-30.
35. Stein DJ, Ipser JC, Seedat S. Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev 2006(1):CD002795.
36. Zohar J, Matar MA, Ifergane G, et al. Brief post-stressor treatment with pregabalin in an animal model for PTSD: Short-term anxiolytic effects without long-term anxiogenic effect. Eur Neuropsychopharmacol 2008;18:653-66.
37. Fowler M, Garza TH, Slater TM, et al. The relationship between gabapentin and pregabalin and posttraumatic stress disorder in burned service members. J Burn Care Res 2012;33:612-8.
38. Pae CU, Marks DM, Han C, et al. Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: An open label pilot study. Int Clin Psychopharmacol 2009;24:29-33.
39. Weathers F, Litz B, Herman D, et al. The PTSD Checklist (PCL): Reliability, validity, and diagnostic utility. Paper presented at the Annual Convention of the International Society for Traumatic Stress Studies, San Antonio, TX; October 1993 (information and current version available at www.ptsd.va.gov/professional/assessment/adult-sr/ptsd-checklist.asp, accessed September 30, 2014).
40. Hamilton M. A rating scale for depression. J Neurol Neuro surg Psychiatry 1960;23:56-62.
41. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-5.
42. Spitzer WO, Dobson AJ, Hall J, et al. Measuring the quality of life of cancer patients: A concise QL-index for use by physicians. J Chronic Dis 1981;34:585-97.
43. Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332 (available at www.consort-statement.org, accessed September 30, 2014).
44. Forbes D, Creamer M, Biddle D. The validity of the PTSD checklist as a measure of symptomatic change in combatrelated PTSD. Behav Res Ther 2001;39:977-86.
45. Norris F, Hamblen J. Standardized self-report measures of civilian trauma and PTSD. In: Wilson J, Keane T, eds. Assessing psychological trauma and PTSD: A practitioner's handbook, second edition. New York: Guilford; 2003: 64-102.
46. Yonkers KA, Samson JA. Mood disorder measures. In: Rush AJ, Jr, First MB, Blacker D, eds. Handbook of psychiatric measures, second edition. Arlington, VA: American Psychiatric Publishing; 2008: 508-11.
47. Rehm LP, O'Hara MW. Item characteristics of the Hamilton Rating Scale for Depression. J Psychiatr Res 1985;19:31-41.
48. Shear M, Brown C, Clark DB. Anxiety disorders measures. In: Rush AJ, Jr, First MB, Blacker D, eds. Handbook of psychiatric measures, second edition. Arlington, VA: American Psychiatric Publishing; 2008: 535-6.
49. Danovitch I, Endicott J. Quality of life measures. In: Rush AJ, Jr, First MB, Blacker D, eds. Handbook of psychiatric measures, second edition. Arlington, VA: American Psychiatric Publishing; 2008: 139-40.
50. Becker CB, Meyer G, Price JS, et al. Law enforcement preferences for PTSD treatment and crisis management alternatives. Behav Res Ther 2009;47:245-53.
51. Paslakis G, Gilles M, Deuschle M. Pregabalin in the treatment of posttraumatic stress disorder: A case report. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:1160-1.